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556a Wednesday, February 6, 2013monofunctional, being capable of only the adenylation of FMN to form FAD.
Studies on bacterial FADS have shown considerable promiscuity in the accep-
tance of altered FMNs as substrates but absolutely no uptake of different nucle-
otide triphosphates (e.g. CTP, TTP, etc.).
Here we show that bacterial FADS (from C. ammoniagenes, CaFADS) will ac-
cept a modified ATP analog, specifically the fluorescent ATP analog aminopur-
ine-2’-deoxyriboside-5’-triphosphate (2ApTP) for the production of dual
fluorescent F-2Ap-D. Surprisingly, preliminary experiments indicate the mono-
functional hFADS is not similarly promiscuous. These results implicate that
this difference in substrate specificity may lead to unique biomarker applica-
tions. Understanding these enzymes may also lead to new approaches in nucle-
oside analog therapeutics.
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Lung collectin surfactant proteins are pulmonary host defense proteins that
contribute to innate, front-line defense against influenza A virus (IAV) and
other inhaled pathogens. Effective pulmonary host defense requires fast recog-
nition by lung surfactant protein D (SP-D) of glycans on the globular head of
IAV hemagglutinin (HA), thereby initiating events leading to pathogen neutral-
ization. In site-directed mutagenesis experiments, a double mutant of human
SP-D, namely R343V/D325A, was found to enhance IAV neutralization activ-
ity. In order to understand the effect of the double mutation on the mechanism
of SP-D recognition and inhibition of IAV HA, we performed molecular dy-
namics simulations on docked SP-D-HA complexes for wild type SP-D
(wtSP-D) and double mutant SP-D (dmSP-D). Our simulations revealed that
side chain properties of the mutated residues and modes of glycan binding
lead to increased binding affinity of dmSP-D to the active site of IVA HA, in-
creasing thereby its antiviral activity.
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Druggability assessment of a target protein is an important concept in drug dis-
covery. Target flexibility and allostery poses challenges to structure based bind-
ing site identification and druggability assessment methods. We developed
a simulation-based methodology for comprehensive analysis of the dynamics
and binding properties of target proteins (1). Two distinguishing features of
the methodology are: (i) simulation of the target in presence of a diversity of
probe molecules selected upon analyzing functional groups on approved drugs,
(ii) identification of druggable sites and estimation of corresponding maximal
affinities based on the geometry and energetics of bound probe clusters. The
use of the methodology for a variety of targets such as PTP1B, lymphocyte
function-associated antigen 1, and vertebrate kinesin-5 (Eg5) provides shows
that the method correctly captures the location and maximal affinities known
bindings sites. It also provides insights into the target’s structural changes
that would accommodate, if not promote and stabilize, drug binding (2). Nota-
bly, the ability to identify high affinity spots even in challenging cases such as
PTP1B or Eg5 shows promise as a rational tool for assessing the druggability of
protein targets, and identifying novel allosteric sites for drug binding. A thor-
ough case study of cytochrome (cyt) c druggability provides further support to
the utility of the methodology for prospective targets with limited structural
data. We identified the pocket facing heme and accessible in the partially un-
folded form of cyt c as a sub-nanomolar druggable site. The first ever pharma-
cophore model developed for cyt c based on these simulations can distinguish
known heme binders and is being advantageously used for discovering new
drug-like inhibitors of cyt c.
1. Bakan A et al. J Chem Theory Comput. 2012 8(7):2435-47.
2. Bakan A, Bahar I. PNAS 2009 106(34):14349-54.
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2Universita` di Trieste, Trieste, Italy, 3T&B associati srl, Trieste, Italy.We present a method to design small peptides able of high affinity binding with
a preselected target molecule. Our algorithm builds on a combination of molec-
ular dynamics, semi-flexible docking and replica exchange Monte Carlo, and
performs simultaneous sampling in sequence and conformational spaces care-
fully selecting the degree of flexibility in the mutated peptides. The approach is
used to design a decapeptide able to bind the anti-HIV drug efavirenz. The cal-
culated binding energy of the designed peptide (approx. 12 kcal/mol) was
confirmed experimentally by fluorescence measurements. NMR spectroscopy
confirmed the interactions between the peptide and the efavirenz molecule pre-
dicted by the algorithm.
2855-Pos Board B10
Protein Kinase G Ligand Binding Specificity via Confine-And-Release
Thermodynamic Integration
Paul M. Gasper1, J. Andrew McCammon1,2.
1University of California - San Diego, La Jolla, CA, USA, 2Howard Hughes
Medical Institute, La Jolla, CA, USA.
Protein Kinase G (PKG) is a second messenger dependent protein implicated in
smooth muscle relaxation. Active PKG signals for blood vessel dilation, mak-
ing it an attractive target in cardiovascular drug discovery. The PKG regulatory
domain consists of two, potentially druggable, cyclic nucleotide binding do-
mains (CNBDs), which activate PKG when simultaneously occupied by
cGMP. Here we contribute to the characterization of each CNBD by examining
its ability to discriminate between cGMP and a highly similar ligand, cAMP.
Relative binding free energies were calculated using molecular dynamic simu-
lations and thermodynamic integration (TI). The contribution of individual res-
idues was assessed by repetition over a series of mutant structures. In some
cases, multiple ligand binding conformations (syn vs. anti about the glycosyl
bond) were found to meaningfully contribute to the binding free energies. As
the barrier to rotation between these conformations prevented adequate sam-
pling on computationally feasible TI timescales, the confine-and-release
method was used to account for the contribution of each conformation. This re-
sulted in improved convergence and agreement with experiment.
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Functional protein-protein interactions are essential formany physiological pro-
cesses andmay play important roles in substrate channeling, coenzyme transfer,
and compartmentation in glycolysis. Herein, Brownian dynamics (BD) eluci-
dates the interactions between the glycolytic enzymes glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) and lactate dehydrogenase (LDH) and
the transfer of the cofactor nicotinamide adenine dinucleotide (NAD) between
LDH and GAPDH. BD channeling simulation results strongly depend on choice
of reactive atom set. When the reactive atoms set comprise of atoms in the
vicinity of the NAD binding site of either enzyme, short NAD trajectories
between enzyme subunits occur. If the reactive atoms set were chosen from
atoms belonging to NAD binding sites, the efficiency of reaching LDH
decreased significantly, and even the shortest trajectories spent time equilibrat-
ing with solvent before binding the next active site. Transfer of NAD from
GAPDH to LDH is sensitive to overall structure of enzyme-enzyme complex.
Small variations in orientation of one enzyme relative to the other cause changes
in channeling efficiency. The process of NAD release from GAPDH and LDH
binding sites was studied with steered molecular dynamics. The GAPDH/LDH
complex with two LDH subunits facing two GAPDH subunits was chosen as
initial structure. Six NADmolecules were included - two molecules in GAPDH
active subunits and 4 NAD molecules bound to each LDH subunit. External
forces were applied to O3 NAD atom of each NAD molecule. MD trajectories
(2 ns) with external force (% 1000 pN) were able to pull the NAD out of
GAPDH, but not out of LDH. Such strong binding of NAD by LDH is because
the nicotinic moiety is buried deep inside LDH subunit globule. Additional
studies are needed to confirm the hypothesis that intermolecular contacts soften
GAPDH subunit and its affinity to NAD reduces.
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Riboflavin ligands present an alternative pathway for targeted drug delivery as
riboflavin receptors are over-expressed in breast and prostate cancer cells. We
have examined a riboflavin conjugated PAMAM dendrimer (generation 5) for
